Loading clinical trials...
Loading clinical trials...
A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
Conditions
Locations
80
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Providence Alaska Medical Center
Anchorage, Alaska, United States
Tucson Cystic Fibrosis Center
Tucson, Arizona, United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Miller Children's and Women's Hospital Long Beach
Long Beach, California, United States
CHOC Children's Hospital
Orange, California, United States
Start Date
August 25, 2020
Primary Completion Date
July 11, 2022
Completion Date
July 11, 2022
Last Updated
December 4, 2024
NCT02417740
NCT06616857
NCT02740868
NCT07108153
NCT07303621
NCT07274631
Lead Sponsor
Nicole Hamblett
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions